Development and Evaluation of Adeno-HTLV-III Hybrid Virus and Non- Cytopathic HTLV-III Mutant for Vaccine Use
Abstract
Acquired immunodeficiency disease syndrome (AIDS ) was initially recognized as a separate disease in 1981. Results from research groups in France and the United States determined that a previously unknown virus called HIV is the primary aetiological agent of AIDS. Two HIV vaccines, a recombinant Adeno- HIV hybrid virus and a recombinant vaccinia HIV will be tested. The recombinant Adeo-HIV virus is being developed as part of this proposal, we will focus on whether generation and cloning of HIV specific killer T cells could be used to protect humans from AIDS.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 28, 1988
- Accession Number
- ADA205753
Entities
People
- Martha T. Lubet
- Sandra K. Dusing